Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Globalstar
GSAT
$10.7B
| $17.4M | ﹤0.01% |
693,590
+317
| +0% | +$7.78K |
|
2052
Enovix
ENVX
$966M
| $17.4M | ﹤0.01% |
1,051,131
+1,031,356
| +5,215% | +$15.5M |
|
2053
Andersons Inc
ANDE
$2.21B
| $17.4M | ﹤0.01% |
563,232
-36,438
| -6% | -$1.05M |
|
2054
Vanda Pharmaceuticals
VNDA
$304M
| $17.3M | ﹤0.01% |
1,010,704
+6,342
| +0.6% | +$111K |
|
|
CANO
2055
DELISTED
Cano Health, Inc.
CANO
| $17.3M | ﹤0.01% |
+13,658
| New | +$16.6M |
|
2056
RB Global
RBA
$16B
| $17.3M | ﹤0.01% |
281,576
+32,276
| +13% | +$1.97M |
|
2057
German American Bancorp
GABC
$1.92B
| $17.3M | ﹤0.01% |
447,809
+7,081
| +2% | +$263K |
|
|
GOEV
2058
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $17.3M | ﹤0.01% |
4,887
+491
| +11% | +$1.75M |
|
|
POLY
2059
DELISTED
Plantronics, Inc.
POLY
| $17.3M | ﹤0.01% |
671,512
+67,691
| +11% | +$2.12M |
|
2060
Heron Therapeutics
HRTX
$63.5M
| $17.2M | ﹤0.01% |
1,612,375
+22,983
| +1% | +$280K |
|
|
ATRI
2061
DELISTED
Atrion Corp
ATRI
| $17.2M | ﹤0.01% |
24,710
+440
| +2% | +$292K |
|
2062
Gogo Inc
GOGO
$377M
| $17.2M | ﹤0.01% |
995,979
+30,664
| +3% | +$371K |
|
2063
Donnelley Financial Solutions
DFIN
$1.22B
| $17.2M | ﹤0.01% |
496,185
+6,222
| +1% | +$205K |
|
|
HSII
2064
DELISTED
Heidrick & Struggles
HSII
| $17.1M | ﹤0.01% |
382,938
-43,927
| -10% | -$1.85M |
|
2065
NETGEAR
NTGR
$647M
| $17.1M | ﹤0.01% |
535,340
-9,005
| -2% | -$312K |
|
2066
Brown-Forman Class A
BF.A
$13.1B
| $17.1M | ﹤0.01% |
272,539
+7,974
| +3% | +$532K |
|
|
SRDX
2067
DELISTED
Surmodics
SRDX
| $17.1M | ﹤0.01% |
306,764
+8,782
| +3% | +$488K |
|
|
AHRT
2068
AH Realty Trust
AHRT
$506M
| $17.1M | ﹤0.01% |
1,275,246
-2,858
| -0.2% | -$37.8K |
|
2069
CTS Corp
CTS
$1.79B
| $17M | ﹤0.01% |
550,874
-7,027
| -1% | -$241K |
|
2070
Rush Street Interactive
RSI
$2.85B
| $17M | ﹤0.01% |
886,396
+6,014
| +0.7% | +$82.3K |
|
|
JOYY
2071
JOYY Inc
JOYY
$3.64B
| $17M | ﹤0.01% |
312,095
+23,061
| +8% | +$1.29M |
|
2072
Upland Software
UPLD
$17.9M
| $17M | ﹤0.01% |
50,771
+3,158
| +7% | +$1.18M |
|
|
DMC
2073
Del Monte Corp
DMC
$1.44B
| $17M | ﹤0.01% |
526,734
+2,185
| +0.4% | +$68.9K |
|
2074
Comstock Resources
CRK
$3.99B
| $16.9M | ﹤0.01% |
1,636,976
+157,890
| +11% | +$1.07M |
|
|
CIO
2075
DELISTED
City Office REIT
CIO
| $16.9M | ﹤0.01% |
948,512
-7,525
| -0.8% | -$110K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.